Citation: Mr. Aboud et Ddf. Ma, A COMPARISON BETWEEN 2 ACTIVATED PROTEIN-C RESISTANCE METHODS AS ROUTINE DIAGNOSTIC-TESTS FOR FACTOR-V-LEIDEN MUTATION, British Journal of Haematology, 97(4), 1997, pp. 798-803
Citation: N. Straetmans et al., EVOLUTION OF BONE-MARROW FIBROSIS AND STROMAL ANTIGENIC EXPRESSION INCHRONIC MYELOID-LEUKEMIA ON ALPHA-INTERFERON AND ARA-C THERAPY, Hematopathology and molecular hematology, 10(4), 1996, pp. 213-222
Citation: Ddf. Ma et Aq. Wei, ENHANCED DELIVERY OF SYNTHETIC OLIGONUCLEOTIDES TO HUMAN LEUKEMIC-CELLS BY LIPOSOMES AND IMMUNOLIPOSOMES, Leukemia research, 20(11-12), 1996, pp. 925-930
Citation: T. Ledoan et al., ANTISENSE OLIGONUCLEOTIDES - PERSPECTIVES FOR A MORE SELECTIVE CHEMOTHERAPY, Annales de medecine interne, 147(8), 1996, pp. 542-552
Authors:
STRAETMANS N
MA DDF
HERMAN P
ZENEBERGH A
CHANG A
DENEYS V
DEBRUYERE M
FERRANT A
Citation: N. Straetmans et al., LONG-TERM CULTURE OF AUTOLOGOUS TRANSPLANTED BONE-MARROW FOR ACUTE MYELOID-LEUKEMIA - EVIDENCE FOR AN IN-VITRO HEMATOPOIETIC DEFECT AND LACK OF CORRELATION WITH THE SPEED OF ENGRAFTMENT, Bone marrow transplantation, 15(3), 1995, pp. 421-428
Citation: Jl. Yin et al., INTERFERON RESPONSE IN CHRONIC MYELOID-LEUKEMIA CORRELATES WITH AEL BCR EXPRESSION - A PRELIMINARY-STUDY/, British Journal of Haematology, 89(3), 1995, pp. 539-545
Citation: Ddf. Ma et al., ACTIVATED PROTEIN-C RESISTANCE (APC) AND INHERITED FACTOR-V (FV) MIS-SENSE MUTATION IN PATIENTS WITH VENOUS AND ARTERIAL THROMBOSIS IN A HEMATOLOGY CLINIC, Australian and New Zealand Journal of Medicine, 25(2), 1995, pp. 151-154
Citation: Bg. Williams et al., A PH(-LEUKEMIA EXPRESSING BOTH CML-TYPE AND ALL-TYPE BCR() ACUTE MYELOID)ABL MESSENGER-RNA TRANSCRIPTS/, Leukemia & lymphoma, 14(3-4), 1994, pp. 341-346
Authors:
MASTRUZZO L
WOISARD A
MA DDF
RIZZARELLI E
FAVRE A
LEDOAN T
Citation: L. Mastruzzo et al., TARGETED PHOTOCHEMICAL MODIFICATION OF HIV-DERIVED OLIGORIBONUCLEOTIDES BY ANTISENSE OLIGODEOXYNUCLEOTIDES LINKED TO PORPHYRINS, Photochemistry and photobiology, 60(4), 1994, pp. 316-322
Authors:
GALA JL
MCLACHLAN JM
BELL DR
MICHAUX JL
MA DDF
Citation: Jl. Gala et al., SPECIFICITY AND SENSITIVITY OF IMMUNOCYTOCHEMISTRY FOR DETECTING P-GLYCOPROTEIN IN HEMATOLOGICAL MALIGNANCIES, Journal of Clinical Pathology, 47(7), 1994, pp. 619-624
Citation: P. Galettis et al., DAUNORUBICIN PHARMACOKINETICS AND THE CORRELATION WITH P-GLYCOPROTEINAND RESPONSE IN PATIENTS WITH ACUTE-LEUKEMIA, British Journal of Cancer, 70(2), 1994, pp. 324-329
Citation: Ddf. Ma et al., FACTOR-V MISSENSE MUTATION AND APC-RESISTANCE IN PATIENTS WITH VENOUSTHROMBOEMBOLISM, Blood, 84(10), 1994, pp. 10000084-10000084
Citation: Ddf. Ma et al., COMBINED ALFA-INTERFERON AND LOW-DOSE ARA-C THERAPY FOR CHRONIC MYELOID-LEUKEMIA AND CORRELATION OF ABL BCR TRANSCRIPT WITH RESPONSE TO INTERFERON, Blood, 84(10), 1994, pp. 10000153-10000153
Citation: Ddf. Ma et T. Ledoan, ANTISENSE OLIGONUCLEOTIDE THERAPIES - ARE THEY THE MAGIC BULLETS, Annals of internal medicine, 120(2), 1994, pp. 161-163
Authors:
STRAETMANS N
FERRANT A
MCLACHLAN J
DENEYS V
MA DDF
BRON D
Citation: N. Straetmans et al., EFFECTS OF INTERLEUKIN-6 ON HEMATOPOIETIC AND STROMAL CELLS IN LONG-TERM BONE-MARROW CULTURE, Experimental hematology, 21(8), 1993, pp. 1184-1184
Authors:
CARTWRIGHT KD
ARTHUR CK
MA DDF
ISBISTER JP
Citation: Kd. Cartwright et al., SHORT INTENSIVE CHEMOTHERAPY (COPE COMP) FOR INTERMEDIATE AND HIGH-GRADE NON-HODGKINS-LYMPHOMA, Blood, 82(10), 1993, pp. 10000561-10000561
Citation: N. Straetmans et Ddf. Ma, CELL-ADHESION MOLECULES AND THEIR ROLE IN HEMATOPOIESIS AND IN HEMATOLOGICAL DISEASES, Australian and New Zealand Journal of Medicine, 23(5), 1993, pp. 504-514
Citation: Ck. Arthur et Ddf. Ma, COMBINED INTERFERON ALFA-2A AND CYTOSINE-ARABINOSIDE AS 1ST-LINE TREATMENT FOR CHRONIC MYELOID-LEUKEMIA, Acta haematologica, 89, 1993, pp. 15-21